Obesity and diabetes in TNF-alpha receptor- deficient mice

S A Schreyer1, S C Chua, R C LeBoeuf

  • 1Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

Insights

Tumor necrosis factor-alpha (TNF) receptor signaling does not drive obesity-related insulin resistance. Instead, TNF receptors appear to protect against diabetes by working together to maintain glucose homeostasis.

Area of Science:

  • Metabolic disease research
  • Immunology
  • Endocrinology

Background:

  • Obesity is frequently linked to insulin resistance.
  • Tumor necrosis factor-alpha (TNF) is hypothesized to mediate this insulin resistance.
  • TNF exerts its effects through p55 and p75 cell surface receptors.

Purpose of the Study:

  • To investigate the role of TNF signaling in glucose homeostasis and insulin resistance.
  • To determine if TNF receptor deficiency exacerbates or ameliorates diet-induced obesity and insulin resistance.

Main Methods:

  • Mice lacking one or both TNF receptors (p55(-)/-, p75(-)/-, p55(-)/-p75(-)/-) were fed a high-fat diet.
  • Obese (db/db) mice with or without p55 receptor expression were analyzed.
  • Fasting insulin, glucose levels, body weight, leptin levels, and glucose/insulin tolerance tests were performed.

Main Results:

  • Mice lacking both TNF receptors (p55(-)/-p75(-)/-) showed marked hyperinsulinemia when fed a high-fat diet.
  • Mice lacking only p75 TNF receptor (p75(-)/-) exhibited reduced body weight, lower leptin levels, and improved insulin sensitivity.
  • In severe obesity models (db/db mice), p55 deficiency did not worsen insulin resistance and led to lower glucose levels.

Conclusions:

  • The data do not support TNF signaling as a major driver of obesity-associated insulin resistance.
  • Conversely, the findings suggest that TNF receptors function cooperatively to protect against the development of diabetes.
  • Targeting TNF receptors may offer a novel therapeutic strategy for metabolic disorders.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.